{"podcast":{"title":"Birmingham News Today | 2 Min News | The Daily News Now!","slug":"birmingham-news-today-2-min-news-the-daily-news-now-7604728","podcast_index_feed_id":7604728,"rss_url":"https://feeds.fastcast.ai/birmingham-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/birmingham-daily-news-now.jpg","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Birmingham News Today delivers fast, focused daily updates on the stories shaping Birmingham, Alabama—from local news and business to culture, sports, and community developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Birmingham News Today is your daily snapshot of what’s happening across the city. Advertise on DNN: advertise@thednn.ai","last_synced_at":null,"page_url":"https://stenobird.com/podcast/birmingham-news-today-2-min-news-the-daily-news-now-7604728"},"episode":{"title":"Daraxonrasib Breaks Pancreatic Cancer Barrier","slug":"daraxonrasib-breaks-pancreatic-cancer-barrier","published_at":"2026-05-31T17:22:07+00:00","page_url":"https://stenobird.com/podcast/birmingham-news-today-2-min-news-the-daily-news-now-7604728/daraxonrasib-breaks-pancreatic-cancer-barrier","show_page_url":"https://stenobird.com/podcast/birmingham-news-today-2-min-news-the-daily-news-now-7604728","url":"https://api.fastcast.ai/audio/467f0f67-3b01-4582-a340-c74eb1e0acfb.mp3","audio_url":"https://api.fastcast.ai/audio/467f0f67-3b01-4582-a340-c74eb1e0acfb.mp3","summary":"A breakthrough pill called daraxonrasib is lighting up hope for advanced pancreatic cancer patients, offering nearly double the survival time compared to standard chemo—with fewer side effects. Targeting the mutated protein behind 90% of these deadly tumors, it’s the first drug to show such dramatic improvement. Doctors are emotional about the results, patients report better quality of life, and the FDA is fast-tracking approval. This could be the long-awaited turning point for a cancer once considered untreatable. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/8a15542396275a58","meta_description":"A breakthrough pill called daraxonrasib is lighting up hope for advanced pancreatic cancer patients, offering nearly double the survival time compared to…","key_points":[],"chapters":[],"topics":[],"duration_seconds":111,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/birmingham-news-today-2-min-news-the-daily-news-now-7604728/episodes/daraxonrasib-breaks-pancreatic-cancer-barrier/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/birmingham-news-today-2-min-news-the-daily-news-now-7604728/daraxonrasib-breaks-pancreatic-cancer-barrier.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}